Every weekday the CNBC Investing Club with Jim Cramer holds a Morning Meeting livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. 1. U.S. equities came under pressure Monday, with the S & P 500 down 0.16% in midmorning trading. The move lower comes after two strong weeks for stocks that has seen Club names like Alphabet (GOOGL), Meta Platforms (META), Amazon (AMZN) and Apple (AAPL) all climb higher since reporting quarterly results. Those gains have come despite little upside surprise in any of their reports and have largely been driven by a retreat in bond yields. “We’ve had a series of ugly wins, but they’re wins,” Jim Cramer said Monday. He added that “homework matters” regardless of support from the bond market, as it helps investors to know when to hold on to quality stocks. Bond yields, meanwhile, were little changed Monday morning, with that of the 10-year Treasury hovering above 4.6%. 2. Over the weekend, Novo Nordisk (NVO) presented the full results from a closely watched study around its GLP-1 weight-loss drug, Wegovy, which has shown a 20% reduction in risks of major adverse cardiovascular events. Wall Street analysts have largely reacted positively to the presentation, with many arguing it should increase prescriptions of GLP-1s and support broader insurance coverage — with positive implications for Novo’s chief rival, Club holding Eli Lilly (LLY). Jim said Monday that there are two factors insurance companies will look at when considering whether to cover these drugs: obesity and blood pressure. “They want blood pressure down,” he added. 3. Piper Sandler said that Club holding Microsoft ‘s (MSFT) Ignite conference , which gets underway Wednesday, “could emerge as the next catalyst” for the software giant’s stock. The company “remains in the early stages of capitalizing on its first-mover advantage in generative AI,” Piper Sandler analysts wrote in a research note Sunday. The company is expected to give updates around its…
Read the full article here
Leave a Reply